Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Sitaxsentan alone

Days 1-5: Sitaxsentan tablet, 100 mg, q24 h (once a day)

DRUG

Sitaxsentan

Days 6-12: Sitaxsentan tablet, 100 mg, q24h (once a day)

DRUG

Rifampin

Days 6-12: Rifampin capsule, 600 mg, q24h (once a day)

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY